Back to LRVIYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen
View Full LandscapeDrug Information
Target Indication
Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen
Clinical Trial
NCT00831025Last updated: 1/22/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Depigoid Parietaria judaica 1000DPP/mlPhase 3
Allergic Rhinoconjunctivitis
Glucosamine and chondroitin sulfate combination (Eurofarma)Phase 3
Osteoarthritis of Knee
Minoxidil Topical FoamPhase 3
Alopecia
Study group - quadrivalent recombinant hemagglutinin influenza vaccinePhase 3
Influenza, Human
Chlorthalidone 25 mg + amiloride hydrochloride 5 mgPhase 3
Arterial Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts